Arquivamento definitivo - Art. 33 da LPI
#11.1.1
10/18/2022
RPI 2702
Application data
Number
112020021721Type
Filing
Publication
PCT
US2019028877 The application was abandoned: examination was not requested within the 36 months following the 04/24/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/18/2022. We update with every new RPI gazette, published weekly.
Applicants
JANSSEN BIOTECH, INC.
US
Inventors
J. S. (pessoa física)
US
IPC Classification
Priority claims
US
62/662,055 · 04/24/2018
US
62/730,478 · 09/12/2018
US
62/778,385 · 12/12/2018
US
62/811,238 · 02/27/2019
Abstract
A presente invenção refere-se aos sintomas da dermatite atópica em um indivíduo humano, que são reduzidos pela administração de uma composição farmacêutica ao indivíduo, que inclui um veículo farmaceuticamente aceitável e uma quantidade terapeuticamente eficaz de um agente que se liga seletivamente à IL-1a.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
10/18/2022
RPI 2702
#11.1
08/02/2022
RPI 2691
#15.35
12/14/2021
RPI 2658
#1.3
01/26/2021
RPI 2612
#1.1
11/03/2020
RPI 2600
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.